Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability, and PK/PD of SRSD107 in healthy participants has completed for the thrombosis indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• SRSD107

Snippet

Sponsor: Sirius Therapeutics Co., Ltd. | Conditions: Thrombosis | Phase 1 | Status: COMPLETED